![]() |
市场调查报告书
商品编码
1306532
冠状动脉球囊导管的全球市场:规模,占有率,COVID-19影响分析(2023年~2029年):MedCore,各类型(PTCA,药物释放型,特殊球囊导管)Coronary Balloon Catheters Market Size, Share & COVID19 Impact Analysis | Global | 2023-2029 | MedCore | Segmented by: Type (PTCA, Drug-Eluting & Speciality Balloon Catheter) |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2022年全球冠状动脉球囊导管市场规模将超过9.63亿美元。预计该市场在预测期内将以 2.3% 的复合年增长率增长,到 2029 年将超过 11 亿美元。
本报告提供全球冠状动脉球囊导管市场相关调查,提供市场概要,以及各市场区隔,各地区趋势,竞争情形等资讯。
In 2022, the global market for coronary balloon catheters exceeded a valuation of $963 million. Over the forecast period, it is projected to experience a compound annual growth rate (CAGR) of 2.3%, reaching a value exceeding $1.1 billion.
The comprehensive report suite encompasses the global market for coronary balloon catheters, which includes percutaneous transluminal coronary angioplasty (PTCA) balloons and specialty balloons. Specialty balloons encompass cutting and scoring balloons.
As part of our study on the global coronary balloon catheter market, iData Research has conducted a comprehensive analysis of angiography, angioplasty (or PCI), atherectomy, and catheterization procedure volumes. This analysis has been performed to enhance the accuracy of our market sizing and provide you with detailed information on procedure volumes spanning a 10-year timeframe across 70 countries. By incorporating procedure volume data, we aim to provide a comprehensive understanding of the market dynamics and trends in the coronary balloon catheter industry.
The primary purpose of coronary balloon catheters is to dilate a vessel before the insertion of a stent. The concerns surrounding late stent thrombosis have contributed to an increase in the number of pre-stent dilation procedures, thereby driving market growth. However, the widespread adoption of drug-eluting stents (DESs) has had a limiting impact on the coronary balloon catheter market. DESs have demonstrated effectiveness in reducing restenosis rates and minimizing the need for pre-stent dilation procedures. While coronary balloon catheters may still be used after DES procedures, the overall reduction in restenosis has resulted in a decrease in unit sales for both percutaneous transluminal coronary angioplasty (PTCA) and specialty balloon catheters.
Boston Scientific holds the top position in the global coronary balloon catheter market, with a strong presence in the percutaneous transluminal coronary angioplasty (PTCA) balloon segment, where it commands a majority share.
Philips entered the market by acquiring Spectranetics, establishing its position primarily in the specialty balloon catheter segment, where it has secured a significant market share.
Medtronic, like other major competitors in the global coronary balloon catheter market, offers a wide range of devices in both the coronary and peripheral markets. This allows the company to strategically bundle products and leverage its position in the competitive landscape.